U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H39N6O9P
Molecular Weight 658.6392
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BMS-986094

SMILES

COC1=NC(N)=NC2=C1N=CN2[C@@H]3O[C@H](COP(=O)(N[C@@H](C)C(=O)OCC(C)(C)C)OC4=CC=CC5=C4C=CC=C5)[C@@H](O)[C@@]3(C)O

InChI

InChIKey=YFXGICNMLCGLHJ-RSKRLRQZSA-N
InChI=1S/C30H39N6O9P/c1-17(26(38)42-15-29(2,3)4)35-46(40,45-20-13-9-11-18-10-7-8-12-19(18)20)43-14-21-23(37)30(5,39)27(44-21)36-16-32-22-24(36)33-28(31)34-25(22)41-6/h7-13,16-17,21,23,27,37,39H,14-15H2,1-6H3,(H,35,40)(H2,31,33,34)/t17-,21+,23+,27+,30+,46?/m0/s1

HIDE SMILES / InChI

Molecular Formula C30H39N6O9P
Molecular Weight 658.6392
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

BMS-986094 (formerly known as INX-189), a nucleotide polymerase (NS5B) inhibitor was developed for the treatment of hepatitis C. Drug participated in phase II clinical trials to evaluate its safety and tolerability. However, in 2012 Bristol-Myers Squibb announced discontinues the development due to safety reasons. The U.S. Food and Drug Administration (FDA) subsequently placed BMS-986094 on clinical hold.

Approval Year

PubMed

PubMed

TitleDatePubMed
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus.
2010 Aug 15
INX-08189, a phosphoramidate prodrug of 6-O-methyl-2'-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties.
2011 May
Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
2011 Oct 1

Sample Use Guides

Tablet, Oral, 25 mg, Once daily (QD), 12 weeks
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 01:28:34 GMT 2023
Edited
by admin
on Sat Dec 16 01:28:34 GMT 2023
Record UNII
62F4AD749Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BMS-986094
Code English
INX-08189
Code English
L-ALANINE, N-(2'-C-METHYL-6-O-METHYL-P-1-NAPHTHALENYL-5'-GUANYLYL)-, 2,2-DIMETHYLPROPYL ESTER
Common Name English
INX 08189
Code English
INX-089
Code English
INX-189
Code English
Code System Code Type Description
SMS_ID
100000175091
Created by admin on Sat Dec 16 01:28:34 GMT 2023 , Edited by admin on Sat Dec 16 01:28:34 GMT 2023
PRIMARY
PUBCHEM
46700744
Created by admin on Sat Dec 16 01:28:34 GMT 2023 , Edited by admin on Sat Dec 16 01:28:34 GMT 2023
PRIMARY
DRUG BANK
DB11966
Created by admin on Sat Dec 16 01:28:34 GMT 2023 , Edited by admin on Sat Dec 16 01:28:34 GMT 2023
PRIMARY
CAS
1234490-83-5
Created by admin on Sat Dec 16 01:28:34 GMT 2023 , Edited by admin on Sat Dec 16 01:28:34 GMT 2023
PRIMARY
FDA UNII
62F4AD749Y
Created by admin on Sat Dec 16 01:28:34 GMT 2023 , Edited by admin on Sat Dec 16 01:28:34 GMT 2023
PRIMARY
EPA CompTox
DTXSID00154017
Created by admin on Sat Dec 16 01:28:34 GMT 2023 , Edited by admin on Sat Dec 16 01:28:34 GMT 2023
PRIMARY